Efficacy and safety of Botulinum Toxin A intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic review
Botulinum toxin A (BoNTA) is increasingly used for therapy of neurogenic detrusor overactivity (NDO) refractory to antimuscarinics or where patients are experiencing antimuscarinic-related side effects.
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2013
|
| In: |
Drugs
Year: 2013, Volume: 73, Issue: 10, Pages: 1055-1066 |
| ISSN: | 1179-1950 |
| DOI: | 10.1007/s40265-013-0068-5 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40265-013-0068-5 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s40265-013-0068-5 
|
| Author Notes: | Irina Soljanik |
| Summary: | Botulinum toxin A (BoNTA) is increasingly used for therapy of neurogenic detrusor overactivity (NDO) refractory to antimuscarinics or where patients are experiencing antimuscarinic-related side effects. |
|---|---|
| Item Description: | Published online: 18 June 2013 Gesehen am 08.02.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1179-1950 |
| DOI: | 10.1007/s40265-013-0068-5 |